Clinical Trials Directory

Trials / Conditions / Vaccination; Infection

Vaccination; Infection

21 registered clinical trials studyying Vaccination; Infection — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingStudy of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Fai
NCT06907667
Centre Hospitalier Universitaire de NiceN/A
RecruitingTriage Survey for Infectious Disease Eligibility
NCT06492187
Brooklyn Clinical Research—
CompletedStudy of the Impact of Time of Vaccination on Response to Influenza Vaccine in Kidney Transplant Recipients -C
NCT06088563
Centre Hospitalier Universitaire de NiceN/A
TerminatedIntradermal Administration of a COVID-19 mRNA Vaccine in Elderly
NCT05977127
Radboud University Medical CenterPhase 2
CompletedMaternal Determinants of Infant Immunity to Pertussis
NCT05856396
Centre Hospitalier Universitaire Saint PierrePhase 4
UnknownEffect of Health Education on Promoting Influenza Vaccination Health Literacy
NCT06048406
Sun Yat-sen UniversityN/A
Active Not RecruitingImmunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV
NCT05898464
Seoul National University HospitalPhase 4
UnknownThe Influence of Trained Immunity in COVID-19 Vaccinated Individuals
NCT05705180
Wuerzburg University Hospital—
UnknownAnti-Schistosomiasis Sm14-vaccine in Senegal
NCT05658614
Oswaldo Cruz FoundationPhase 2
UnknownEstablishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine
NCT05315362
Leiden University Medical CenterPhase 2
UnknownPost Covid-19 Vaccination Development or Flare of ARD
NCT05160428
Cairo University—
RecruitingThe Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
NCT04970836
National Taiwan University HospitalN/A
CompletedMonitoring COVID-19 Vaccination Response in Fragile Populations
NCT05222139
University of Bologna—
UnknownRisk of COVID-19 Infection After Vaccination
NCT04848441
Umeå University—
UnknownImmune Response to Vaccination Against Covid-19, a Follow up Study
NCT04920357
Umeå University—
CompletedTrial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years
NCT05470582
St. Petersburg Research Institute of Vaccines and SeraPhase 3
CompletedMaternal Determinants of Immunity to Influenza
NCT06716567
Centre Hospitalier Universitaire Saint PierrePhase 4
CompletedTolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vac
NCT05869201
St. Petersburg Research Institute of Vaccines and SeraPhase 2 / Phase 3
CompletedCOVID-19 Serology in People Living with HIV in Hong Kong
NCT05028881
Chinese University of Hong Kong—
CompletedTrial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine
NCT05457894
St. Petersburg Research Institute of Vaccines and SeraPhase 3
CompletedMood and Influenza Vaccine Response: A Feasibility Trial
NCT03144518
University of NottinghamN/A